FDA Committee Recommends, Moderna Booster Shots.
On Oct. 14, an FDA committee
unanimously recommended
booster shots of the Moderna vaccine
for at-risk Americans.
69 Million people have
recieved the first two doses
of the Moderna vaccine.
Booster shots of the Pfizer-BioNTech
vaccine were approved last month
for certain individuals.
The FDA's ultimate decision
will be confirmed in the coming days.
The booster shots must be approved by
the FDA and endorsed by
the Centers for Disease Control and Prevention.
Some scientists contend it's too soon to distribute booster shots in the United States.
Most who have recieved two doses of the Moderna vaccine are still protected against the virus.
If we’re trying to prevent what is inevitable, which is a decline in neutralizing antibodies and an erosion in protection against mild or asymptomatic infection, that is a high bar to which we hold no other vaccine, Dr. Paul Offit, panel member, via CNBC.
United States Health Officials hope that the
extra doses will offer sustained protection
against hospitalizations and death.
Early data suggests that those who had received
a booster shot of the coronavirus vaccine
were less likely to become seriously ill
